XOMA Royalty Corporation (XOMA) Stock
XOMA is no longer traded. XOMA Royalty was delisted from the Nasdaq in July 2026.
Prices on this page are historical; the last trade was July 13, 2026 at $40.17.
XOMA Royalty stock price history
XOMA final trading statistics
- Final close
- $40.17
- Final trading day
- Jul 13, 2026
- Market cap at delisting
- $710.16M
- Shares outstanding
- 17.68M
- Final 52-week range
- $22.29 – $45.22
- Avg. volume (final 3 mo.)
- 335,228
- All-time high (split-adj.)
- $9600.00 · Mar 1987
- All-time low (split-adj.)
- $4.03 · Feb 2017
- Return since IPO
- -99.2%
- Beta
- 0.86
- Book value / share
- $7.79
- Price / book
- 5.15
XOMA Royalty annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $52.15M | $31.7M | $1.28 |
| FY2024 | $28.49M | -$13.8M | -$1.67 |
| FY2023 | $4.76M | -$40.8M | -$2.66 |
| FY2022 | $6.03M | -$17.1M | -$1.96 |
| FY2021 | $38.16M | $15.8M | $0.17 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. As of July 14, 2026, XOMA Royalty Corporation operates as a subsidiary of Ligand Pharmaceuticals Incorporated.
XOMA Royalty stock FAQ
What happened to XOMA Royalty stock?
XOMA Royalty stock was delisted from the Nasdaq. Its final close was $40.17 on July 13, 2026.
Is XOMA stock still trading?
No. XOMA was delisted from the Nasdaq in July 2026 and no longer trades on a U.S. exchange.
What was the last price of XOMA stock?
XOMA closed at $40.17 on its final trading day, July 13, 2026, for a market value of about $710.16M.
What were XOMA Royalty's revenue and earnings in its last full fiscal year?
XOMA Royalty reported revenue of $52.15M and net income of $31.7M in fiscal 2025, its last full year as a public company.
When did XOMA Royalty go public?
XOMA Royalty Corporation stock began trading on April 5, 1989.